» Articles » PMID: 35154078

Identification and Tracking of Alloreactive T Cell Clones in Rhesus Macaques Through the RM-scTCR-Seq Platform

Overview
Journal Front Immunol
Date 2022 Feb 14
PMID 35154078
Authors
Affiliations
Soon will be listed here.
Abstract

T cell receptor (TCR) clonotype tracking is a powerful tool for interrogating T cell mediated immune processes. New methods to pair a single cell's transcriptional program with its TCR identity allow monitoring of T cell clonotype-specific transcriptional dynamics. While these technologies have been available for human and mouse T cells studies, they have not been developed for Rhesus Macaques (RM), a critical translational organism for autoimmune diseases, vaccine development and transplantation. We describe a new pipeline, 'RM-scTCR-Seq', which, for the first time, enables RM specific single cell TCR amplification, reconstruction and pairing of RM TCR's with their transcriptional profiles. We apply this method to a RM model of GVHD, and identify and track detected alloreactive clonotypes in GVHD target organs and explore their GVHD driven cytotoxic T cell signature. This novel, state-of-the-art platform fundamentally advances the utility of RM to study protective and pathogenic T cell responses.

Citing Articles

B-cell-directed CAR T-cell therapy activates CD8+ cytotoxic CARneg bystander T cells in patients and nonhuman primates.

Kaminski J, Fleming R, Alvarez-Calderon F, Winschel M, McGuckin C, Ho E Blood. 2024; 144(1):46-60.

PMID: 38558106 PMC: 11561542. DOI: 10.1182/blood.2023022717.


Barcode clonal tracking of tissue-resident immune cells in rhesus macaque highlights distinct clonal distribution pattern of tissue NK cells.

Wu C, Liang J, Brenchley J, Shin T, Fan X, Mortlock R Front Immunol. 2023; 13:994498.

PMID: 36605190 PMC: 9808525. DOI: 10.3389/fimmu.2022.994498.


T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy.

Frank M, Lu K, Erdogan C, Han Y, Hu J, Wang T Clin Cancer Res. 2022; 29(6):994-1008.

PMID: 36413126 PMC: 10011887. DOI: 10.1158/1078-0432.CCR-22-2469.


Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD.

Buxbaum N, Socie G, Hill G, MacDonald K, Tkachev V, Teshima T Blood Adv. 2022; 7(17):4886-4902.

PMID: 36322878 PMC: 10463203. DOI: 10.1182/bloodadvances.2022007611.

References
1.
Graubert T, Russell J, Ley T . The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood. 1996; 87(4):1232-7. View

2.
Rempala G, Seweryn M . Methods for diversity and overlap analysis in T-cell receptor populations. J Math Biol. 2012; 67(6-7):1339-68. PMC: 3543521. DOI: 10.1007/s00285-012-0589-7. View

3.
Watkins B, Tkachev V, Furlan S, Hunt D, Betz K, Yu A . CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates. J Clin Invest. 2018; 128(9):3991-4007. PMC: 6118599. DOI: 10.1172/JCI98793. View

4.
Suessmuth Y, Mukherjee R, Watkins B, Koura D, Finstermeier K, Desmarais C . CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire. Blood. 2015; 125(25):3835-50. PMC: 4473113. DOI: 10.1182/blood-2015-03-631853. View

5.
Buggert M, Vella L, Nguyen S, Wu V, Chen Z, Sekine T . The Identity of Human Tissue-Emigrant CD8 T Cells. Cell. 2020; 183(7):1946-1961.e15. PMC: 9341432. DOI: 10.1016/j.cell.2020.11.019. View